Validity and reliability of the migraine-treatment optimization questionnaire

Richard B. Lipton, K. Kolodner, M. E. Bigal, D. Valade, M. J A Láinez, J. Pascual, A. Gendolla, G. Bussone, N. Islam, K. Albert, B. Parsons

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ) in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ, and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSQoL)]. A 15-item (M-TOQ-15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were identified: functioning, rapid relief, consistency of relief, risk of recurrence and tolerability; with Cronbach alphas of 0.70-0.84. The Cronbach α for M-TOQ-15 was 0.85, and it correlated well with MIDAS, HIT-6 and MSQoL (r = 0.33-0.44). The Cronbach α for M-TOQ-5 was 0.66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated.

Original languageEnglish (US)
Pages (from-to)751-759
Number of pages9
JournalCephalalgia
Volume29
Issue number7
DOIs
StatePublished - Jul 2009

Fingerprint

Migraine Disorders
Reproducibility of Results
Therapeutics
Headache
Surveys and Questionnaires
Primary Health Care
Quality of Life
Headache Disorders
Recurrence

Keywords

  • Migraine
  • Reliability
  • Treatment optimization
  • Validity

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Lipton, R. B., Kolodner, K., Bigal, M. E., Valade, D., Láinez, M. J. A., Pascual, J., ... Parsons, B. (2009). Validity and reliability of the migraine-treatment optimization questionnaire. Cephalalgia, 29(7), 751-759. https://doi.org/10.1111/j.1468-2982.2008.01786.x

Validity and reliability of the migraine-treatment optimization questionnaire. / Lipton, Richard B.; Kolodner, K.; Bigal, M. E.; Valade, D.; Láinez, M. J A; Pascual, J.; Gendolla, A.; Bussone, G.; Islam, N.; Albert, K.; Parsons, B.

In: Cephalalgia, Vol. 29, No. 7, 07.2009, p. 751-759.

Research output: Contribution to journalArticle

Lipton, RB, Kolodner, K, Bigal, ME, Valade, D, Láinez, MJA, Pascual, J, Gendolla, A, Bussone, G, Islam, N, Albert, K & Parsons, B 2009, 'Validity and reliability of the migraine-treatment optimization questionnaire', Cephalalgia, vol. 29, no. 7, pp. 751-759. https://doi.org/10.1111/j.1468-2982.2008.01786.x
Lipton, Richard B. ; Kolodner, K. ; Bigal, M. E. ; Valade, D. ; Láinez, M. J A ; Pascual, J. ; Gendolla, A. ; Bussone, G. ; Islam, N. ; Albert, K. ; Parsons, B. / Validity and reliability of the migraine-treatment optimization questionnaire. In: Cephalalgia. 2009 ; Vol. 29, No. 7. pp. 751-759.
@article{8f8057cad49a4ca0b41a4bf1c2a29cf1,
title = "Validity and reliability of the migraine-treatment optimization questionnaire",
abstract = "Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ) in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ, and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSQoL)]. A 15-item (M-TOQ-15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were identified: functioning, rapid relief, consistency of relief, risk of recurrence and tolerability; with Cronbach alphas of 0.70-0.84. The Cronbach α for M-TOQ-15 was 0.85, and it correlated well with MIDAS, HIT-6 and MSQoL (r = 0.33-0.44). The Cronbach α for M-TOQ-5 was 0.66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated.",
keywords = "Migraine, Reliability, Treatment optimization, Validity",
author = "Lipton, {Richard B.} and K. Kolodner and Bigal, {M. E.} and D. Valade and L{\'a}inez, {M. J A} and J. Pascual and A. Gendolla and G. Bussone and N. Islam and K. Albert and B. Parsons",
year = "2009",
month = "7",
doi = "10.1111/j.1468-2982.2008.01786.x",
language = "English (US)",
volume = "29",
pages = "751--759",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Validity and reliability of the migraine-treatment optimization questionnaire

AU - Lipton, Richard B.

AU - Kolodner, K.

AU - Bigal, M. E.

AU - Valade, D.

AU - Láinez, M. J A

AU - Pascual, J.

AU - Gendolla, A.

AU - Bussone, G.

AU - Islam, N.

AU - Albert, K.

AU - Parsons, B.

PY - 2009/7

Y1 - 2009/7

N2 - Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ) in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ, and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSQoL)]. A 15-item (M-TOQ-15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were identified: functioning, rapid relief, consistency of relief, risk of recurrence and tolerability; with Cronbach alphas of 0.70-0.84. The Cronbach α for M-TOQ-15 was 0.85, and it correlated well with MIDAS, HIT-6 and MSQoL (r = 0.33-0.44). The Cronbach α for M-TOQ-5 was 0.66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated.

AB - Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ) in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ, and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSQoL)]. A 15-item (M-TOQ-15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were identified: functioning, rapid relief, consistency of relief, risk of recurrence and tolerability; with Cronbach alphas of 0.70-0.84. The Cronbach α for M-TOQ-15 was 0.85, and it correlated well with MIDAS, HIT-6 and MSQoL (r = 0.33-0.44). The Cronbach α for M-TOQ-5 was 0.66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated.

KW - Migraine

KW - Reliability

KW - Treatment optimization

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=66749156463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66749156463&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2008.01786.x

DO - 10.1111/j.1468-2982.2008.01786.x

M3 - Article

C2 - 19239676

AN - SCOPUS:66749156463

VL - 29

SP - 751

EP - 759

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 7

ER -